Literature DB >> 15958074

Innate immune responses in Lyme borreliosis: enhanced tumour necrosis factor-alpha and interleukin-12 in asymptomatic individuals in response to live spirochetes.

J Sjöwall1, A Carlsson, O Vaarala, S Bergström, J Ernerudh, P Forsberg, C Ekerfelt.   

Abstract

Innate immunity is important for early defence against borrelia spirochetes and should play a role in the clinical outcome of the infection. In order to study early cytokine responses, in vitro differentiated dendritic cells (DCs) and whole blood cells from 21 patients with different clinical outcomes of Lyme neuroborreliosis were stimulated with live borrelia spirochetes. The borrelia-induced secretion of interleukin (IL)-4, IL-10, IL-12p70, interferon (IFN)-gamma and tumour necrosis factor (TNF)-alpha in DCs and IL-1beta, IL-6, IL-8, IL-10, IL-12p70, TNF-alpha, regulated upon activation normal T cell expressed and secreted (RANTES), monocyte chemoattractant protein (MCP)-1, macrophage inflammatory protein (MIP)-1alpha, MIP-1beta and eotaxin in whole blood cells was measured by enzyme-linked immunospot (ELISPOT) and multiplex arrays, respectively. We found increased numbers of TNF-alpha-secreting DCs (P = 0.018) in asymptomatic seropositive individuals compared to patients with subacute neuroborreliosis and seronegative controls. Asymptomatic individuals were also found to have elevated levels of IL-12p70 (P = 0.031) in whole blood cell supernatants compared to seronegative controls. These results are in line with previous experiments using cells of the adaptive immune response, indicating that strong T helper type 1 (Th1) proinflammatory responses might be associated with a successful resolution of Lyme disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15958074      PMCID: PMC1809414          DOI: 10.1111/j.1365-2249.2005.02820.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  53 in total

1.  Activation of monocytes by three OspA vaccine candidates: lipoprotein OspA is a potent stimulator of monokines.

Authors:  T Häupl; S Landgraf; P Netusil; N Biller; C Capiau; P Desmons; P Hauser; G R Burmester
Journal:  FEMS Immunol Med Microbiol       Date:  1997-09

2.  Clinical and serologic follow-up in patients with neuroborreliosis.

Authors:  J Treib; A Fernandez; A Haass; M T Grauer; G Holzer; R Woessner
Journal:  Neurology       Date:  1998-11       Impact factor: 9.910

3.  Augmented intrathecal secretion of interferon-gamma in response to Borrelia garinii in neuroborreliosis.

Authors:  C Ekerfelt; J Ernerudh; P Forsberg; S Bergström
Journal:  J Neuroimmunol       Date:  1998-08-14       Impact factor: 3.478

4.  Borrelia burgdorferi-pulsed dendritic cells induce a protective immune response against tick-transmitted spirochetes.

Authors:  M L Mbow; N Zeidner; N Panella; R G Titus; J Piesman
Journal:  Infect Immun       Date:  1997-08       Impact factor: 3.441

5.  Asymptomatic Borrelia-seropositive individuals display the same incidence of Borrelia-specific interferon-gamma (IFN-gamma)-secreting cells in blood as patients with clinical Borrelia infection.

Authors:  C Ekerfelt; P Forsberg; M Svenvik; M Roberg; S Bergström; J Ernerudh
Journal:  Clin Exp Immunol       Date:  1999-03       Impact factor: 4.330

6.  Compartmentalization of antigen specific cytokine responses to the central nervous system in CNS borreliosis: secretion of IFN-gamma predominates over IL-4 secretion in response to outer surface proteins of Lyme disease Borrelia spirochetes.

Authors:  C Ekerfelt; J Ernerudh; J Bunikis; M Vrethem; J Aagesen; M Roberg; S Bergström; P Forsberg
Journal:  J Neuroimmunol       Date:  1997-11       Impact factor: 3.478

7.  Borrelia burgdorferi spirochetes induce mast cell activation and cytokine release.

Authors:  J Talkington; S P Nickell
Journal:  Infect Immun       Date:  1999-03       Impact factor: 3.441

8.  Stages and syndromes of neuroborreliosis.

Authors:  P Oschmann; W Dorndorf; C Hornig; C Schäfer; H J Wellensiek; K W Pflughaupt
Journal:  J Neurol       Date:  1998-05       Impact factor: 4.849

9.  IgG subclasses in Lyme borreliosis: a study of specific IgG subclass distribution in an interferon-gamma-predominated disease.

Authors:  M Widhe; C Ekerfelt; P Forsberg; S Bergström; J Ernerudh
Journal:  Scand J Immunol       Date:  1998-06       Impact factor: 3.487

10.  Reversibility of T helper 1 and 2 populations is lost after long-term stimulation.

Authors:  E Murphy; K Shibuya; N Hosken; P Openshaw; V Maino; K Davis; K Murphy; A O'Garra
Journal:  J Exp Med       Date:  1996-03-01       Impact factor: 14.307

View more
  16 in total

1.  Mercury exposure as a model for deviation of cytokine responses in experimental Lyme arthritis: HgCl2 treatment decreases T helper cell type 1-like responses and arthritis severity but delays eradication of Borrelia burgdorferi in C3H/HeN mice.

Authors:  C Ekerfelt; M Andersson; A Olausson; S Bergström; P Hultman
Journal:  Clin Exp Immunol       Date:  2007-08-02       Impact factor: 4.330

2.  Interleukin-10 alters effector functions of multiple genes induced by Borrelia burgdorferi in macrophages to regulate Lyme disease inflammation.

Authors:  Aarti Gautam; Saurabh Dixit; Mario T Philipp; Shree R Singh; Lisa A Morici; Deepak Kaushal; Vida A Dennis
Journal:  Infect Immun       Date:  2011-09-26       Impact factor: 3.441

3.  Interleukin-10 anti-inflammatory response to Borrelia burgdorferi, the agent of Lyme disease: a possible role for suppressors of cytokine signaling 1 and 3.

Authors:  Vida A Dennis; Ayanna Jefferson; Shree R Singh; Frédéric Ganapamo; Mario T Philipp
Journal:  Infect Immun       Date:  2006-10       Impact factor: 3.441

4.  Statins reduce spirochetal burden and modulate immune responses in the C3H/HeN mouse model of Lyme disease.

Authors:  Tricia A Van Laar; Camaron Hole; S L Rajasekhar Karna; Christine L Miller; Robert Reddick; Floyd L Wormley; J Seshu
Journal:  Microbes Infect       Date:  2016-03-16       Impact factor: 2.700

5.  Viable Borrelia burgdorferi enhances interleukin-10 production and suppresses activation of murine macrophages.

Authors:  John J Lazarus; Maria A Kay; Akisha L McCarter; R Mark Wooten
Journal:  Infect Immun       Date:  2007-12-17       Impact factor: 3.441

6.  Decreased Th1-type inflammatory cytokine expression in the skin is associated with persisting symptoms after treatment of erythema migrans.

Authors:  Johanna Sjöwall; Linda Fryland; Marika Nordberg; Florence Sjögren; Ulf Garpmo; Christian Jansson; Sten-Anders Carlsson; Sven Bergström; Jan Ernerudh; Dag Nyman; Pia Forsberg; Christina Ekerfelt
Journal:  PLoS One       Date:  2011-03-31       Impact factor: 3.240

7.  Adaptive and innate immune responsiveness to Borrelia burgdorferi sensu lato in exposed asymptomatic children and children with previous clinical Lyme borreliosis.

Authors:  Barbro H Skogman; Sandra Hellberg; Christina Ekerfelt; Maria C Jenmalm; Pia Forsberg; Johnny Ludvigsson; Sven Bergström; Jan Ernerudh
Journal:  Clin Dev Immunol       Date:  2011-12-05

8.  Indications of Th1 and Th17 responses in cerebrospinal fluid from patients with Lyme neuroborreliosis: a large retrospective study.

Authors:  Anna J Henningsson; Ivar Tjernberg; Bo-Eric Malmvall; Pia Forsberg; Jan Ernerudh
Journal:  J Neuroinflammation       Date:  2011-04-20       Impact factor: 8.322

9.  Stimulated Immune Response by TruCulture® Whole Blood Assay in Patients With European Lyme Neuroborreliosis: A Prospective Cohort Study.

Authors:  Mathilde Ørbæk; Rosa Maja Møhring Gynthersen; Helene Mens; Christian Stenør; Lothar Wiese; Christian Brandt; Sisse Rye Ostrowski; Susanne Dam Nielsen; Anne-Mette Lebech
Journal:  Front Cell Infect Microbiol       Date:  2021-05-10       Impact factor: 5.293

10.  Increased prevalence of Borrelia burgdorferi infections in Bernese Mountain Dogs: a possible breed predisposition.

Authors:  Bernhard Gerber; Simone Eichenberger; Max M Wittenbrink; Claudia E Reusch
Journal:  BMC Vet Res       Date:  2007-07-12       Impact factor: 2.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.